scPharmaceuticals Inc.

NASDAQ: SCPH · Real-Time Price · USD
4.71
-0.24 (-4.85%)
At close: Aug 15, 2025, 2:35 PM

scPharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
36.33M 13.59M n/a n/a
Cost of Revenue
11.36M 3.81M 468K 438K
Gross Profit
24.97M 9.78M -468K -438K
Operating Income
-64.78M -55.4M -36.16M -25.82M
Interest Income
3.44M 5.1M 1.2M 49K
Pretax Income
-85.15M -54.81M -36.84M -28.03M
Net Income
-85.15M -54.81M -36.84M -28.03M
Selling & General & Admin
77.65M 53.37M 20.62M 9.78M
Research & Development
12.1M 11.81M 15.53M 16.04M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
89.75M 65.18M 36.16M 25.82M
Interest Expense
7.57M 8.12M 3.3M 2.58M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
101.11M 68.99M 36.16M 25.82M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
44.52M 38.51M 28.36M 27.35M
Shares Outstanding (Diluted)
44.52M 38.51M 28.36M 27.35M
EPS (Basic)
-1.91 -1.42 -1.3 -1.02
EPS (Diluted)
-1.91 -1.42 -1.3 -1.02
EBITDA
-77.43M -46.06M -33.07M -25.02M
EBIT
-77.58M -46.69M -33.54M -25.46M
Depreciation & Amortization
148K 626K 468K 438K